Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
The Sixth Circuit has found the $2.35 billion Dow Corning settlement trust for women with defective breast implants can begin paying out $50 million in second-tier claims early, saying there was sufficient evidence that there will be money left over when the last of the first-tier claims are filed next year.
Massachusetts federal prosecutors on Thursday fought a bid by Insys Therapeutics Inc. executives embroiled in an alleged conspiracy to bribe doctors into prescribing fentanyl-based drugs to disclose grand jury instructions, arguing the government did not wrongly explain the conspiracy charges.
A Kansas federal judge on Friday dressed down attorneys in multidistrict litigation over EpiPen price hikes for engaging in “mindless bickering” during a high-stakes deposition of Mylan NV’s chief executive officer.
New Jersey-based Merck & Co. Inc. said on Friday that it has agreed to buy all outstanding shares of privately-held animal intelligence technology group Antelliq Group for €2.1 billion ($2.4 billion) and assume its debt in a deal that was guided by Covington & Burling LLP.
AstraZeneca has hit more generic-drug makers with a patent infringement suit in New Jersey federal court over a generic alternative to Faslodex, its injection-administered drug for battling breast cancer past menopause.